Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
13.98
-0.61 (-4.18%)
Mar 31, 2025, 1:39 PM EDT - Market open

Centessa Pharmaceuticals Statistics

Total Valuation

CNTA has a market cap or net worth of $1.86 billion. The enterprise value is $1.49 billion.

Market Cap 1.86B
Enterprise Value 1.49B

Important Dates

The last earnings date was Monday, March 24, 2025, before market open.

Earnings Date Mar 24, 2025
Ex-Dividend Date n/a

Share Statistics

CNTA has 133.18 million shares outstanding. The number of shares has increased by 19.02% in one year.

Current Share Class n/a
Shares Outstanding 133.18M
Shares Change (YoY) +19.02%
Shares Change (QoQ) +13.59%
Owned by Insiders (%) 1.40%
Owned by Institutions (%) 64.00%
Float 91.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 4.82
P/TBV Ratio 4.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.25, with a Debt / Equity ratio of 0.29.

Current Ratio 9.25
Quick Ratio 9.09
Debt / Equity 0.29
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -19.93

Financial Efficiency

Return on equity (ROE) is -73.93% and return on invested capital (ROIC) is -29.91%.

Return on Equity (ROE) -73.93%
Return on Assets (ROA) -26.82%
Return on Invested Capital (ROIC) -29.91%
Return on Capital Employed (ROCE) -38.75%
Revenue Per Employee n/a
Profits Per Employee -$3.06M
Employee Count 77
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CNTA has paid $2.84 million in taxes.

Income Tax 2.84M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +31.44% in the last 52 weeks. The beta is 1.52, so CNTA's price volatility has been higher than the market average.

Beta (5Y) 1.52
52-Week Price Change +31.44%
50-Day Moving Average 16.43
200-Day Moving Average 14.66
Relative Strength Index (RSI) 38.85
Average Volume (20 Days) 1,070,843

Short Selling Information

Short Interest 4.86M
Short Previous Month 5.46M
Short % of Shares Out 4.32%
Short % of Float n/a
Short Ratio (days to cover) 4.53

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -201.06M
Pretax Income -163.67M
Net Income -235.76M
EBITDA -200.71M
EBIT -201.06M
Earnings Per Share (EPS) -$2.06
Full Income Statement

Balance Sheet

The company has $482.18 million in cash and $117.83 million in debt, giving a net cash position of $364.35 million or $2.74 per share.

Cash & Cash Equivalents 482.18M
Total Debt 117.83M
Net Cash 364.35M
Net Cash Per Share $2.74
Equity (Book Value) 401.55M
Book Value Per Share 3.03
Working Capital 478.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$142.06 million and capital expenditures -$34,000, giving a free cash flow of -$142.09 million.

Operating Cash Flow -142.06M
Capital Expenditures -34,000
Free Cash Flow -142.09M
FCF Per Share -$1.07
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -19.02%
Shareholder Yield -19.02%
Earnings Yield -12.71%
FCF Yield -7.66%

Analyst Forecast

The average price target for CNTA is $25.63, which is 83.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target $25.63
Price Target Difference 83.33%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -22.90%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2